Research support from SINGAPORE

Research article Journal of Cancer Science and Clinical Therapeutics

Pharmacodynamic Evaluation of AUM001/Tinodasertib, an Oral Inhibitor of Mitogen-Activated Protein Kinase (MAPK)-Interacting Protein Kinase 1, 2 (MNK1/2) in Preclinical Models and Tissues from a Phase 1 Clinical Study

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved!